8.70% (1D)
| Bid | 7.4 |
| Market Cap | 8.43M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -30.8 |
| PE Ratio (ttm) | -0.24 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 7.64 |
| Volume | 42,180 |
| Avg. Volume (20D) | 155,226 |
| Open | 6.74 |
| Previous Close | 6.90 |
| Day's Range | 6.68 - 7.64 |
| 52-Week Range | 6.68 - 100.80 |
| Beta | undefined |
2 months ago
HCW Biologics shares are trading higher after the ...
Unlock content with
Pro Subscription
5 months ago
HCW Biologics shares are trading higher after the company entered into an exclusive licensing deal with WY Biotech for immunotherapy development.
